NCT04093167
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04093167
Title Study of CTDNA Response Adaptive Immuno-Chemotherapy in Lung Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Canadian Cancer Trials Group
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | CAN

Facility Status City State Zip Country Details
The University of Chicago Medical Center Chicago Illinois 60637 United States Details
The Sidney Kimmel Comprehensive Cancer Centre Baltimore Maryland 21231 United States Details
Cross Cancer Institute Edmonton Alberta T6G 1Z2 Canada Details
BCCA - Vancouver Vancouver British Columbia V5Z 4E6 Canada Details
Health Sciences North Greater Sudbury Ontario P3E 5J1 Canada Details
Juravinski Cancer Centre at Hamilton Health Sciences Hamilton Ontario L8V 5C2 Canada Details
Kingston Health Sciences Centre Kingston Ontario K7L 2V7 Canada Details
Ottawa Hospital Research Institute Ottawa Ontario K1H 8L6 Canada Details
Algoma District Cancer Program Sault Ste. Marie Ontario P6B 0A8 Canada Details
University Health Network Toronto Ontario M5G 2M9 Canada Details
The Jewish General Hospital Montreal Quebec H3T 1E2 Canada Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field